Aegis's Novel Psychoactive Substance (NPS) Testing Menu Update

In September, Aegis updated both urine and oral fluid novel psychoactive substance (NPS) test menus as a continued commitment to offering providers a contemporary…

InterACT Rx Pharmacodynamic Insights: A Brief Look at QTc Prolongation, Serotonin Syndrome, and Tardive Dyskinesia

Introduction Some combinations of medications can lead to serious pharmacodynamic interactions with clinical effects that can be life-threatening in some…

Complexities of Risk Assessment: Opioids, Drug Interactions, & Designer Benzodiazepines

As the number of fatal and non-fatal overdoses continues to rise, we should question why this is occurring. One frequent cause of death in drug overdose…

Behavioral Health: Why Monitor Patients for Medication Adherence?

Mental health illness affects almost a half billion people globally every year including millions of Americans. Data from 2020 showed that 21% of Americans…

Novel Psychoactive Substances (NPS): What's New in 2022

Novel Psychoactive Substances (NPS) are a diverse group of synthetic substances created to mimic the effects of scheduled or illicit drugs. There are various…

InterACT Rx: A Look at Clinical Utility Through a Discussion of Interactions Found

InterACT Rx Overview Since 2016, Aegis Sciences Corporation has offered definitive testing for numerous substances that may contribute to drug-drug interactions…

BioDetect: Identifying Non-Urine Substances

Healthcare providers rely on medication compliance test results to assist in measuring compliance and establishing recent substance use. Providers must…